BLUE
SKstacykess.bsky.social

Also, in case anyone wondered, remdesivir messes with your stomach. Just an FYI.

0
Rerlangen.bsky.social

COVID Virus Is Evolving Resistance to Antiviral Treatment www.newsweek.com/covid-virus-... Antiviral drug remdesivir is recommended for use against mild to moderate SARS-CoV-2 infections to reduce the risk of progression to more severe symptoms and hospitalization in high-risk individuals

COVID virus is evolving resistance to antiviral treatment, studies show
COVID virus is evolving resistance to antiviral treatment, studies show

Immunocompromised patients are particularly likely to see the evolution of these mutants, but the risk to the general public remains unclear.

0
SKstacykess.bsky.social

Ok. I know what I say won't matter, but I'm on day 7 of my second CoVid infection in a month. This one is bad. Still running fevers. I'm getting IV remdesivir for this. So news that only 25% of you are going to get a vaccine for flu and CoVid? 1/ www.upi.com/Health_News/...

Survey: Most Americans won't get new flu, COVID-19 vaccines - UPI.com
Survey: Most Americans won't get new flu, COVID-19 vaccines - UPI.com

Most Americans don't plan to get vaccinated against the flu or COVID-19 this season, a new survey has found.

1
Mgnostichippie.bsky.social

most of the meds I gave during covid were of dubious value (hello $1000/bottle remdesivir) which made the ensuing antivaxx turn so frustrating

1
CKcrof.bsky.social
DRdricks.bsky.social

Recall: Gilead pharmaceutical company, maker of Covid antiviral, remdesivir, is voluntarily recalling 1 lot of the medication because a customer found a particle of glass in a vial. Remdesivir is sold under the brand name Veklury. Recall involves the injectable100 mg vial www.fda.gov/safety/recal...

0
GAalt-text.bsky.social

Alt text retrieved

Confidential and Pre-decisional Outcome of All ACTIV Agents Selected and Tested Through 2024 OX TESTED-UNSUCCESSFUL AT • Cenicriviroc • AZD7442 (IM)" (Outpatient) • AZD7442 (IV)" (Outpatient) INTERIM • Camostat Mesylate • BMS-986414/BMS- 986413 .LY-COV-555 (Inpatient) . . Brii-196/Brii-198 (Inpatient) VIR-7831 • DARPin MP0420 Pfizer PF-07304814" Aviptadil + Remdesivir (ARDS patients) • Remdesivir (ARDS patients)** Therapeutic Heparin + P2Y12 Inhibitors in Moderately-ill Pts • Crizanlizumab Aspirin Apixaban** • TRV027 • TXA127 • SGLT2 inhibitors • Fostamatinib TESTED-UNSUCCESSFUL AT FINAL TESTED- SUCCESSFUL • Infliximab OUTCOME ⚫Risankizumab . Lenzilumab Danicopan . Ivermectin (400) Ivermectin (600) . Fluticasone Fluvoxamine (50) • Fluvoxamine (100) . Prophylactic Heparin + P2Y12 Inhibitors in Critically-ill Pts Montelukast Shionogi-217622 (Did not meet primary endpoint in outpatient study in standard risk patients) Abatacept • Brii-196/Brii-198* (Outpatient) .LY-COV-555* (Outpatient)
EMORY EMORY EMORY EMORY Un-fractionated and Low Molecular Weight Heparin EMONY MORY FMORY B FMORY BANKY B EMORY . AZD7442 (IV)* (Inpatient) EMORY EMORY FMOKY FMA WY FAR WIT IMOWY MORY DMORY EMORY (MOWY BAW CAWY EMORY EMORY EMORY EMWY FAROWY BMWY EMORY EMOET FMORY IMCRY EMORY EMORY EMORY MANY BA BANY EMORY ill Timothy Buchman NOT YET DETERMINED NIH National Institutes of Health SNG001 IFN-beta (Phase 2)** SAB-185** Shionogi-217622 (Inpatient) Metformin *Received EUA or data from an ACTIV trial has or will contribute to an EUA filing **Ceased due to operational futility #Ceased due to company decision
0
JRjohnrossmd.bsky.social

The late Francisco Marty was a great champion of this drug in the early months of the pandemic. I used to run into him at all hours when he was recruiting patients for the first remdesivir study. You can enjoy some of Francisco’s amazing photography here: 500px.com/p/fmarty?vie...

0
JRjohnrossmd.bsky.social

New large retrospective study showing that remdesivir + dexamethasone is associated with a lower risk of death, compared to dexamethasone alone, for hospitalized COVID patients. (TBH, kind of amazed that there were enough COVID patients who didn’t get remdesivir to do this analysis) #IDSky

Lower mortality risk associated with remdesivir + dexamethasone versus dexamethasone alone for the treatment of patients hospitalized for COVID-19
Lower mortality risk associated with remdesivir + dexamethasone versus dexamethasone alone for the treatment of patients hospitalized for COVID-19

AbstractBackground. Treatment guidelines were developed early in the pandemic when much about COVID-19 was unknown. Given the evolution of SARS-CoV-2, real

1